Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–4 of 4 stories
Generate Biomedicines, an AI-driven biotech startup, has filed for an IPO after raising over $800 million for its drug discovery efforts. The company is developing a potential competitor to Tezspire for asthma treatment and plans to advance another drug into clinical trials in early 2024.
Read full storyEli Lilly reported $19.3 billion in revenue for Q4 and is expanding its GLP-1 franchise into immunology and inflammation. Ongoing trials target asthma, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
The CDC reports a decline in asthma death rates among children under 18 since 1999, highlighting progress in managing childhood asthma. This report underscores the importance of continued advocacy and awareness efforts in addressing this public health issue.
CDC reports indicate improvements in health insurance coverage for children since 2005, though overall coverage varies significantly by state. The reports also highlight trends in health habits and the prevalence of conditions like diabetes and asthma.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.